Literature DB >> 646869

Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamine.

L L Simpson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 646869

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  3 in total

1.  Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.

Authors:  J P Finberg; M Tenne
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

2.  Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

Authors:  J P Finberg; M Tenne; M B Youdim
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

3.  Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.

Authors:  S E Smith; J Lambourn; P J Tyrer
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.